PRC/IX Capital Fund, United States.
Title of Talk: The Future of Healthspan Investing: Current Landscape and Emerging Opportunities in the Precision Economy
Category: Oral Presentation
Ivan Maranciola is the Co-Founder and CEO of PRCNX Capital Fund, a private investment firm focused on the Precision and Longevity Economy With over 25 years of experience at the intersection of biotechnology, molecular wellness, and preventive healthcare, he has founded and led pioneering ventures much as Pylife Group, Gematama, Asper Biotech, and Longevity Gate Hish, Longevity Advisers. Seats on the Board Blevw, Elisir Clinic and MyShinlat. Aroong others be has been an early stage Investor in NAJClinic, Prion Peptides and Youn life. His work bridges science, consumer health, and investment strategy, redelining the future of healthspan thermagh scalable innovation and sustainable impact across Europe and the Middle East
Empowering Innovation Through Global Conferences and Events.
© 2025 SciInov. All Rights Reserved.